Bladder cancer is a common urologic cancer whose incidence continues to rise annually.
Urinary microparticles are an attractive material for noninvasive bladder cancer biomarker …

In this study, we evaluated the reproducibility of abundant urine protein depletion by
hexapeptide-based library beads and an antibody-based affinity column using the iTRAQ technique…

Large-scale metabolomics study requires a quantitative method to generate metabolome
data over an extended period with high technical reproducibility. We report a universal …

A urine sample preparation workflow for the iTRAQ (isobaric tag for relative and absolute
quantitation) technique was established. The reproducibility of this platform was evaluated and …

Three common urological diseases are bladder cancer, urinary tract infection, and hematuria.
Seventeen bladder cancer biomarkers were previously discovered using iTRAQ — these …

Navigating efficiently and safely through human crowds is essential for mobile robots in diverse
applications such as delivery services, home assistance, healthcare, and manufacturing. …

Bladder cancer is one of the most common urinary tract carcinomas in the world. Urine
metabolomics is a promising approach for bladder cancer detection and marker discovery since …

Valproic acid (VPA) is an established drug in the long-term therapy of seizure disorders.
Recently, VPA has been associated with anticancer activity, an effect thought to be mediated …

More than 380,000 new cases of bladder cancer are diagnosed worldwide, accounting for
∼150,200 deaths each year. To discover potential biomarkers of bladder cancer, we …

In this study, we describe the urinary quantification of apolipoprotein A II protein (APOA2
protein), a biomarker for the diagnosis of bladder cancer, using an n-type polycrystalline silicon …